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Anti-retroviral drugs an reduce plasma HIV viral load
by 3 to 4 orders of magnitude raising the possibility that
treatment can be used not only to save individual lives
but also to stop transmission. Modelling studies suggest
that with the effective use of ART transmission of HIV
could be eliminated within ten years and HIV infection
within 40 years. The ides of using treatment as preven-
tion has generated considerable interest and a certain
amount of controversy. This presentation will describe
the potential impact of treatment-as-prevention,c o m -
pare the results with treatment-as-prophylaxis, and con-
sider some of the key factors that could compromise the
impact of this approach. These include coverage, com-
pliance, the extent of viral load suppression, the reduc-
tion in transmission, the likelihood of virological failure,
viral rebound and drug resistance. Possible ways of
increasing the impact through targeting of the interven-
tion will be discussed. Finally, some consideration will
be given as to how best to test and possibly implement
a programme of using treatment as prevention.
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